GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » Purchase Of Investment

Kimia Biosciences (BOM:530313) Purchase Of Investment : ₹ Mil (TTM As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences Purchase Of Investment?

Kimia Biosciences's purchase of investment for the six months ended in . 20 was ₹0.00 Mil. It means Kimia Biosciences spent ₹0.00 Mil on purchasing investments.

Compared with last quarter (₹0.00 Mil in . 20 ), Kimia Biosciences spent the same money on purchasing investments in . 20 (₹0.00 Mil).


Kimia Biosciences Purchase Of Investment Historical Data

The historical data trend for Kimia Biosciences's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences Purchase Of Investment Chart

Kimia Biosciences Annual Data
Trend
Purchase Of Investment

Kimia Biosciences Semi-Annual Data
Purchase Of Investment

Kimia Biosciences Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.


Kimia Biosciences Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Kimia Biosciences's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Kimia Biosciences (BOM:530313) Business Description

Traded in Other Exchanges
N/A
Address
Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences (BOM:530313) Headlines

No Headlines